Oncotelic Therapeutics, Inc. Investing Cash Flow
Oncotelic Therapeutics, Inc. (OTLC) reported Investing Cash Flow of $189.29 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-04-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2021-04-15
- Oncotelic Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2019-12-31 was $6.40K.
- Oncotelic Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2019-09-30 was $0.00.
- Oncotelic Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2017-12-31 was $0.00.
- Oncotelic Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2011-03-31 was -$12.00K.
- Oncotelic Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2019 was $189.29K.
- Oncotelic Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2017 was $8.51M.
- Oncotelic Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2013 was -$35.00K.
- Oncotelic Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2012 was -$8.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $6.40K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | $6.40K derived: sum of 2 quarters · filed 2021-04-15 | $189.29K 10-K · filed 2021-04-15 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $182.88K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $182.88K 10-Q · filed 2020-08-14 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | $8.51M 10-K · filed 2019-04-10 | ||
| 2017-09-30 | $8.51M 10-Q · filed 2018-11-14 | |||
| 2013-12-31 | -$35.00K 10-K · filed 2014-03-20 | |||
| 2012-12-31 | -$8.00K 10-K · filed 2014-03-20 | |||
| 2011-03-31 | -$12.00K 10-Q · filed 2012-05-11 | -$49.00K derived: sum of 2 quarters · filed 2013-03-15 | -$47.00K derived: sum of 3 quarters · filed 2013-03-15 | |
| 2010-12-31 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$35.00K derived: sum of 2 quarters · filed 2013-03-15 | $3.00K 10-K · filed 2013-03-15 | |
| 2010-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $40.00K 10-Q · filed 2011-11-10 | ||
| 2010-06-30 | $38.00K 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $2.93M 10-K · filed 2012-03-28 |